Latest news with #PGT-M
The Print
5 days ago
- Health
- The Print
NEX IVF Strengthens Patna's Position as a Hub for Advanced Fertility Solutions
New Delhi [India], June 18: As awareness and acceptance of assisted reproductive technologies have increased, the need and demand for specialized fertility care have risen in the capital of Bihar, Patna. In this new environment, specialized medical institutions are instrumental in closing the gap between high-tech treatment and availability. One of the elements of such change is NEX IVF & Fertility Centre, which was launched by senior consultant Dr. Swati Mishra, who has more than 15 years of clinical experience in the field of gynecology, obstetrics, and the management of infertility issues. Dr. Swati Mishra is a graduate of RIMS Ranchi with a DNB in Obstetrics & Gynaecology, and she also received training in IVF protocols, laparoscopy, hysteroscopy, and reproductive sonology. It is not only the scholarship that has marked her medical path but also exposure to the practical aspects of the job at premier institutes such as KHFH Patna and Prachi Hospital Odisha, where she trained in endoscopy. She has published several research papers on national platforms over the years and has contributed to medical journals, which makes her one of the voices of authority on the subject of reproductive health in women. The facilities at NEX IVF are in tandem with the present universal standards in fertility services. The facility, which has an advanced embryology laboratory equipped and built according to Class 10,000 air quality standards, provides precision-based procedures such as ERA, MACS, PGT-A, PGT-M, and NICS. These advancements have improved the success rate of treatments, especially for patients who had consistently experienced IVF failures. According to medical onlookers, these developments place the center among the elite IVF centers in Patna, combining clinical excellence with patient-focused care. The unique factor about NEX is that it focuses on both transparent medical communication and ethical treatment pathways, which are frequently mentioned among the primary reasons for rising patient trust. The center serves a broad range of reproductive problems, including IUI, IVF, ICSI, recurrent pregnancy loss management, and pre-conception genetic counseling. These are in addition to the minimally invasive surgical procedures such as laparoscopy and hysteroscopy, which affirm its status as a super-speciality IVF center in Patna. The patients, too, have acknowledged the unwavering emphasis on individual programs under the care of Dr. Swati Mishra. She is scientifically accurate and at the same time compassionate in approaching sensitive fertility journeys, which makes her a reliable guide for individuals or couples seeking long-term solutions. Even though the city is still emerging as a medical tourism location, analysts see facilities such as NEX IVF & Fertility Centre as a means of transforming the approach to reproductive health in Eastern India. To most people in the area and beyond, the center is increasingly being recognized as one of the best IVF centers in Patna Bihar, not just in terms of numbers, but in terms of the quality, ethics, and result-oriented approach it employs in the profession. (ADVERTORIAL DISCLAIMER: The above press release has been provided by VMPL. ANI will not be responsible in any way for the content of the same) This story is auto-generated from a syndicated feed. ThePrint holds no responsibility for its content.
Khaleej Times
27-02-2025
- Health
- Khaleej Times
UAE: After losing first baby to rare genetic disorder, Dubai couple welcomes miracle child via IVF
When Aysha and Ahmed (names changed upon request) married in 2019, they were excited about their future and planned to grow their family. Aysha soon conceived, and the couple was overjoyed. However, their happiness was short-lived as one of the several tests during pregnancy revealed that the foetus was affected by Beckwith-Wiedemann Syndrome (BWS). The couple's first child did not survive. Beckwith-Wiedemann Syndrome is a genetic condition that causes excessive growth in different body parts. Babies born with BWS are often larger than usual, and some may experience disproportionate growth on one side of the body, a condition known as hemihyperplasia. Although children affected by BWS may grow taller than their peers, the condition typically slows down by age 8, and adult height tends to be normal. Despite the promising recovery with age, BWS increases the risk of childhood cancers, making it a difficult condition for parents. Aysha and Ahmed, originally from Jordan and long-time residents of Dubai, were heartbroken after losing their first child. But they were determined not to let the condition affect their future children. 'We learned that one of us carried the genetic mutation for BWS. We really wanted a healthy pregnancy and child, so we decided to go for in vitro fertilisation (IVF),' said Aysha. After undergoing IVF treatment, Aysha and Ahmed were able to welcome a healthy baby boy. Their son was free from the genetic disorder thanks to advanced fertility treatments and genetic testing. "We are very happy that our son is healthy and disease-free," said the mother. The couple consulted doctors at Orchid Fertility Clinic, where the team used Preimplantation Genetic Testing for Monogenic Diseases (PGT-M) to prevent the hereditary condition from being passed down. Dr Dimitrios Kafetzis, the medical director at Orchid Fertility, explained the challenges the couple faced, including advanced maternal age and a history of miscarriages. 'Our team employed a combination of advanced genetic screening and IVF techniques to help the couple conceive a healthy child while minimising the risk of passing on BWS,' said Dr Kafetzis. The IVF process began with ovarian stimulation over four cycles, resulting in the retrieval of 57 mature eggs. These eggs were fertilised via Intracytoplasmic Sperm Injection (ICSI), and 41 embryos developed. 'Genetic testing identified seven embryos that were free of the BWS mutation, and further screening for chromosomal abnormalities narrowed the selection down to two viable embryos, one of which was successfully implanted,' said Dr Kafetzis. 'The pregnancy progressed well, and the baby was born healthy,' said Maria Banti, lab director at Orchid Fertility. 'This case demonstrates the potential of reproductive genetics in preventing inherited conditions and ensuring better outcomes for families facing genetic challenges.' Now, the couple is determined to expand their family. They have embarked on their second round of IVF, hopeful that they will be blessed with another child free from genetic disorders.
USA Today
19-02-2025
- Politics
- USA Today
Ashley St. Clair posted about using CRISPR to conceive Musk's child? Not true
Ashley St. Clair posted about using CRISPR to conceive Musk's child? Not true | Fact check Show Caption Hide Caption Musk's son attends Oval Office as Trump signs executive order Elon Musk attended the Oval Office with his son X as President Donald Trump signed an executive order to give Musk more power over federal workers. The claim: Image shows author's post about conceiving child with Elon Musk using CRISPR, 'enhancements from other organisms' A Feb. 16 Facebook post (direct link, archive link) shows a screenshot of what appears to be an X post from conservative author Ashley St. Clair about a child she said she conceived with billionaire Elon Musk 'Elon and I used IVF with PGT-M & CRISPR to ensure our baby had the best traits,' the text of the supposed post reads in part. 'Our little one's DNA now includes enhancements from other organisms for superior intelligence & health and we couldn't be happier.' CRISPR is a technology that allows scientists to "selectively modify the DNA of living organisms," according to the National Human Genome Research Institute. The Facebook post was shared more than 300 times in three days. The image also circulated on X, Instagram and elsewhere on Facebook. More from the Fact-Check Team: How we pick and research claims | Email newsletter | Facebook page Our rating: Manipulated media The image is a fabrication, a spokesperson for St. Clair said. Her X profile contains no record of the post attributed to her. 'Counterfeit' post attributed to St. Clair St. Clair – a conservative influencer, author and commentator – said in a Feb. 14 X post that Musk is the father of the child she gave birth to in 2024 and accused 'tabloid media' of attempting to make it public knowledge. Musk – the world's wealthiest person who is already the father of 12 children with at least three women, USA TODAY previously reported – had not responded to the claim as of Feb. 18. Fact check: No, Elon Musk didn't post 'cool' image of himself behind Oval Office desk The X post attributed to her in the Feb. 16 Facebook post, however, is a fabrication. St. Clair spokesperson Brian Glicklich described it as 'counterfeit.' There is no record of that post on her account. The image includes what appears to be a timestamp indicating it was shared Feb. 16 at '7:21' – without indicating whether that time is AM or PM, as authentic posts on the platform do. Regardless, her profile contains no evidence that she shared a post at either time. Versions of the image circulating on social media each indicate it had been viewed 173 times when it was captured – an indication it is a fabrication that traces to a single source. Were it real, it surely would have been captured and shared with varying numbers of views by her more than 1 million followers. USA TODAY previously debunked false claims that Musk donated $10 million to support the families of Jan. 6 defendants, shared a post threatening to suspend X users who protest President Donald Trump's administration and banned LGBTQ Pride references on the X platform. USA TODAY reached out to several social media users who shared the image but did not immediately receive any responses. Lead Stories also debunked the claim. Our fact-check sources Brian Glicklich, Feb. 18, Email exchange with USA TODAY Ashley St. Clair, accessed Feb. 18, X account National Human Genome Research Institute, accessed Feb. 19, CRISPR Thank you for supporting our journalism. You can subscribe to our print edition, ad-free app or e-newspaper here. USA TODAY is a verified signatory of the International Fact-Checking Network, which requires a demonstrated commitment to nonpartisanship, fairness and transparency. Our fact-check work is supported in part by a grant from Meta.
